Bioconjugated gold nanoparticles enhance siRNA delivery in prostate cancer cells

Research output: Chapter in Book/Report/Conference proceedingsChapterpeer-review

Abstract

Here we describe a simple way to create a gold nanoparticle (AuNP)-based non-viral delivery system to deliver siRNA into prostate cancer cells. Therefore, positively charged polyethylenimine (PEI)-capped AuNPs were synthesized in water and further conjugated with the targeting ligand (folic acid) for folate receptors (AuNPs-PEI-FA). The AuNPs-PEI-FA could effectively complex small interfering RNA (siRNA) through electrostatic interaction. Flow cytometry displayed that AuNPs-PEI-FA could specifically deliver siRNA into LNCaP cells, a prostate cancer cell line overexpressing prostate-specific membrane antigen (PSMA) that exhibits a hydrolase enzymatic activity with a folate substrate. In contrast, internalization of siRNA into PC-3 cells, a prostate cancer cell line not expressing PSMA or folate receptors, was not achieved using AuNPs-PEI-FA.siRNA. Following endolysosomal escape, the AuNPs-PEI-FA-.siRNA formulation resulted in significant endogenous gene silencing when compared to the nontargeted formulation, suggesting the potential of AuNPs-PEI-FA for targeted delivery of therapeutic siRNAs in the treatment of prostate cancer.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages291-301
Number of pages11
DOIs
Publication statusPublished - 2019

Publication series

NameMethods in Molecular Biology
Volume1974
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • Gene therapy
  • Gold nanoparticles
  • Non-viral siRNA delivery
  • Prostate cancer
  • Receptor-mediated internalization
  • Targeting ligands

Fingerprint

Dive into the research topics of 'Bioconjugated gold nanoparticles enhance siRNA delivery in prostate cancer cells'. Together they form a unique fingerprint.

Cite this